LPJ Seminar ISPST by Anisa Amalia, Anisa
LAPORAN KEGIATAN 
THE 4th INTERNATIONAL SEMINAR ON  
PHARMACEUTICAL SCIENCE AND TECHNOLOGY 
Online Seminar 





1. Anisa Amalia, M.Farm 












PROGRAM STUDI FARMASI 
FAKULTAS FARMASI DAN SAINS 
UNIVERSITAS MUHAMMADIYAH PROF. DR. HAMKA 
JAKARTA 
 
A. Surat tugas 
 
B. Brosur informasi kegiatan 
 
  





D. Poster yang dipresentasikan 
 
 
E. Bukti pembayaran kegiatan 
 
 




Physical Properties and Rate of Diffusion Transethosome 
Curcumin using  a Combination of Tween 60 and Span 60 as 
Surfactant 
 
ANISA AMALIA*, YUDI SRIFIANA, AMALIA ANWAR 
 
Faculty Pharmacy and Sains, Universitas Muhammadiyah Prof. DR. HAMKA,  










Jl. Delima II/IV, Malaka Sari, Jakarta Timur 13460 
E-Mail: anisa.amalia@uhamka.ac.id 
Curcumin penetration can be increased by formulating it into 
the transethosome system. Surfactant is one of the transethosome component that 
affect the physical properties and penetration of vesicles.In this study, a 
combination of two surfactants was used to see the effect of using a combination 
of two surfactant on physical properties and penetration of curcumin. This study 
used a combination of tween 60 and span 60 with a concentration ratio 0:5 (F1), 
1:1 (F2), 2:1 (F3) and 1:2 (F4). An evaluation included testing the distribution of 
particle size, zeta potential and entrapment efficiency in the system. Evaluation 
continued with the determination of the diffusion rate in 
vitro. The transethosome system formed has a particle size of 167.9±4.7 nm - 
396±3.7 nm with a potential zeta value (-) 49.54±1.77 mV - (-) 59.05±0.95 mV, 
polydispersion index 0.0% - 57.1% and entrapment efficiency of 83.76% - 
93.75%. Diffusion rate testing results show that the use of a surfactant 
combination can increase the diffusion rate of curcumin, where there is a 
significant differential between each formula (p<0.05). 
Keywords: Curcumin, transethosome, surfactant, physical properties, diffusion rate.  
Curcumin is a yellow compound in turmeric ( Curcuma longa Linn), and has 
activities such as antimicrobial, anti-inflammatory, antioxidant, and 
anticancer. Curcumin has a low solubility in water, is metabolized first by causing 
its bioavailability to decrease[1]. This problem can be overcome by 
formulating curcumin into the form of a transethosome delivery system.  
Transethosome is a lipid vesicle originating 
from transfersome and ethosome which is characterized by the presence of high 
concentrations of surfactants and ethanol. Surfactant is a component that 
affects transethosome penetration. Surfactants have role in elasticity and 
penetration in the transethosome system[2-3]. 
Previous research showed that the transethosome system can increase 
voriconazole penetration and has a higher penetration rate than 
the liposome and ethosome system[4].  Shen et al. have been doing research on 
technology vesicles transethosome using a single surfactant tween 60 and span 
60[5]. The study showed transethosomes can increase the rate of penetration, but 
produce vesicles are unstable. Effect of increasing the penetration rate of drug 
using the transethosome system is also seen in the results of research conducted 
by Grag et al., in that study, the surfactant used was span 80 with a concentration 
of 77.64 % and produced a stable vesicle system[6]. However, the use of 
surfactants with high concentrations can cause an irritating effect on the skin, so it 
needs a combination of surfactants to reduce irritation to the skin and was 
expected to increase the rate of penetration of vesicles. Surfactants that has the 
ability to enter the phospholipid bilayer is tween 60 and span 60. Tween 60 and 
span 60 are nonionic surfactants that can maintain a balance between hydrophilic 
and lipophilic groups, non-toxic, and when combined have low potential to cause 
hypersensitivity reactions[7]. Therefore, it is necessary to research the effect of 
using tween 60 and span 60 as surfactants on the physical properties and diffusion 
rate of curcumin transethosome. 
MATERIALS AND METHODS 
Curcumuin (Gift from Insular Multi Natural, Indonesia), lecithin (Purchased from 
Sunshine, Indonesia), Tween 60 (Purchased from Clorogen, Indonesia), Span 60 
(Purchased form Clorogen, Indonesia), millipore membrane (Purchased form 
Asian, Indonesia), ethanol, sodium hydroxide, potassium dihydrogen phospate ( 
Purchased form Merck, Indonesia). 
Formulation and production of curcumin transethosome 
This research is an experimental study that begins with the stage of 
making transethosome curcumin with the various concentrations of surfactant 
(tween 60 and span 60), and continues to observe the physical properties of the 
transethosome system. Formula of transethosome curcumin can be seen in Table 
1. 
Transethosome curcumin was made using the cold method. Lecithin was 
dispersed with ethanol at 30o C (lipid phase). Surfactants and curcumin are added 
into the lipid phase and homogenized with a magnetic stirrer at 750 rpm for 5 
minutes to form a colloidal system. Then add water to the colloidal system little 
by little in a constant flow, stirring for 5 minutes to form a suspension 
of transethosome curcumin vesicle.The size of the vesicles was reduced by 
sonication for 15 minutes[3,8].  
Evaluation of Transethosome Containing Curcumin 
Determination of Particle Size, Polidispersity Index and Zeta Potensial 
Determination of particle size distribution, polydispersity index value, and 
potential zeta value were measured using a particle size analyzer (Delsa Nano 
Beckman Coulter, USA)[3,9]. 
Determination of entrapment efficiency of curcumin 
Determination of the efficiency of curcumin entrapment was done by 
centrifugation method at a speed of 4000 rpm for 2 hours. Sediment was dissolved 
with ethanol, taken 10.0 ml then put into a 100.0 ml measuring flask. Ethanol is 
added to the measuring flask boundary line. The solution was measured with a 
UV/Vis spectrophotometer (Shimadzu, Japan) at a wavelength of 425.5 nm.  The 
concentration of absorbed curcumin obtained was converted to a unit of weight 
and the percent efficiency calculation is calculated using the formula[10]: 
% Entrapment efficiency =
Amount of entrpament curcumin
Total curcumin
 x 100% 
Transethosome Diffusion Test 
The diffusion test was carried out using a milipore membrane that is placed 
between two parts of the diffusion cell. The receptor compartment was 
conditioned at 37oC by flowing water of the same temperature in 
a water bath. The receptor compartment was filled with phosphate buffer pH 7.4 
and ethanol as much as 5 % to 150 ml then as much as 1 ml of the test sample is 
applied to the membrane surface. Samples were taken as much as 5 ml at interval 
times for 8 hours. Every sampling was replaced by phosphate buffer pH 7.4 with 
addition of ethanol 5 % as much as 5 ml. Absorption 
was measured at a wavelength of 421.0 nm. The absorbance value obtained was 
entered into the linear regression equation to find the diffused percent. Then a 
curve is made between percent diffused with time[11]. 
Analysis of Diffusion Rate Kinetics Model 
Equation line regression linear for each model of the kinetics of the rate 
of diffusion is made by: Zero order kinetics, first order kinetics, Higuchi model 
and Korsmayer-peppas model[12-13]. 
RESULTS AND DISCUSSION 
The particle size distribution and potential zeta value are the most 
important physical properties of the transetosome. Transethosome is a lipd-based 
delivery system that is included in the nanoparticle delivery system. The 
nanoparticle delivery system is a delivery system which has a particle size of 1 - 
1000 nm[14]. The results obtained from this test can be seen in Table 2. The Table 
2 showed the average transethosome curcumin particle size of each formula is still 
included in the nanometer criteria (1-1000 nm). This result proves the formula and 
conditions for making transethosome curcumin can produce vesicles with 
nanometer size with polidispersion percent values 0.0-57.1. The polidispersion 
index value is a parameter that shows the particle size distribution of the 
dispersion system.  The smaller the polydispersion index value, the resulting 
dispersion system the more homogeneous the particle size of the system[15].  
Zeta potential is an important parameter for characterizing nano particles, aimed 
at predicting the stability of colloid solutions. Nanoparticles with potential zeta 
values above (+/-) 30 mV have been shown to be stable because surface charges 
prevent particle aggregation[15,16]. The potential values obtained from each of 
these formulas are -52.54 ± 0.93 mV; -49.54 ± 1.77 mV; - 50.10 ± 0.52 mV; -
59.05 ± 0.95 mV. This results showed, each of the transethosome formula is 
stable because the values of zeta potential obtained above the value of -30 mV, so 
that the possibility of smaller particle aggregation.  
The entrapment efficiency value of  curcumin can be seen in Fig 1. The results 
showed the efficiency of curcumin entrapment was still above 80% so it can be 
concluded that transethosome can entrap curcumin quite well. The entrapment 
efficiency value also shows the use of a combination of surfactants can increase 
the entrapment efficiency, where the entrapment efficiency of F2 with a ratio of 
Tween and Span 1:1 (F2) was the system with the highest absorption 
efficiency. This results are in accordance with the results of research conducted by 
Lv et al., where the results obtained indicate that the combination of tween - span 
nonionic surfactants will increase the efficiency of entrapment[17]. 
The cumulative amount of curcumin diffused through the millipore membrane of 
F1, F2, F3, and F4 for 8 hours (Table 3). The results of the cumulative amount of 
curcumin showed that the surfactant combination provides better penetration 
ability compared to a single surfactant. Based on these results, the highest amount 
of diffused curcumin was at F4 with a ratio of tween 60 and span 60 (2:1). This 
can be influenced by particle size. The particle size of F4 is 167.9 ± 4.7 nm. The 
smaller the particle size, the greater the surface area, causing rapid drug 
release[18]. Based on the cumulative amount of diffused curcumin, it could be 
calculated the diffused curcumin cumulative persentation of each formula was 
23.02 ± 2.12 %, 33.11 ± 2.4 %, 24.85 ± 0.5 %, 93.77 ± 0.29 %.  
The results of the transethosome diffusion test curcumin can then be analyzed to 
determine the mechanism of drug release from the transethosome system (Table 3 
dan Fig 2). The mechanism of drug release can be known by calculating the 
linearity value of several drug release equations, such as zero-order kinetics (Fig 
3), first-order kinetics (Fig 4), Higuchi (Fig 5) and Korsmeyer-Peppas (Fig 6)[13, 
19, 20].  The results of the analysis of drug release mechanisms can be seen in Table 
4. Based on the highest coefficient (R) in the table shows that the diffusion rate 
kinetics in F1 and F3 follow the Higuchi kinetics model. Drug release that follows 
Higuchi kinetics model illustrates drug release that is affected by time[19, 20]. The 
release kinetics of F2 follow zero order kinetics with a value of R = 0.9942. The 
kinetics of zero-order release describe the release of drugs slowly and always 
constant over time. Increased drug concentration is directly proportional to 
time. The kinetics of F4 release followed the Kormeyer-Peppas kinetics that was 
R = 0.9872 with an n value of 0.1484. The value of n obtained is lower than that 
set by Ritger and Peppas which is <0.45. The low value of n is likely due to the 
large size and erosion distribution[19]. The value of n obtained can be determined 
that the process occurs through the mechanism of Fickian diffusion[13, 20]. In 
Fickian diffusion, the rate of release is independent of the drug concentration[18]. 
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TABLE 1: FORMULATION OF TRANSETHOSOME CURCUMIN  
No. Material 
Formula (%) 
F1 F2 F3 F4 
1 Curcumin 1 1 1 1 
2 Lechitin 10 10 10 10 
3 Tween 60 - 2.5 3.33 1.67 
4 Span 60 5 2.5 1.67 3.33 
5 Ethanol 30 30 30 30 
6 Aquades ad 100 100 100 100 
  
TABLE 2: TEST RESULTS OF THE  PARTICLE SIZE, POLYDIPERSION 
INDEX AND ZETA POTENSIAL OF TRANSETHOSOME CURCUMIN 
Formula 
Test result 
Particle Size (nm)a Polydispersion (%)b Zeta potential (mV)c 
F1 350.4 ± 6.7 0.0 -52.54 ± 0.93 
F2 263.4 ± 2.4 57.1 -49.54 ± 1.77 
F3 396.0 ± 3.7 0.0 -50.10 ± 0.52 








TABLE 3 : CUMULATIVE RELEASE OF CURCUMIN 
Time 
(minutes) 
Cumulative release of Curcumin (μg) 
F1a F2b F3c F4d 
5 28.68 ± 5.58 62.45 ± 7.60 41.40 ± 1.44 77.37 ± 3.72 
10 33.85 ± 3.61 70.95 ± 1.72 55.90 ± 5.94 94.45 ± 9.40 
15 42.55 ± 0.35 80.00 ± 8.58 67.97 ± 1.05 106.70 ± 7.90 
20 47.95 ± 2.19 86.97 ± 9.93 91.47 ± 1.79 117.95 ± 1.93 
25 52.00 ± 2.26 94.83 ± 1.25 103.10 ± 1.61 138.70 ± 6.93 
30 57.55 ± 0.49 103.80 ± 1.14 119.43 ± 1.51 150.80 ± 7.07 
35 64.50 ± 3.25 117.40 ± 1.62 137.03 ± 2.57 163.15 ± 7.28 
40 72.95 ± 5.16 132.17 ± 1.97 152.25 ± 2.89 179.75 ± 1.91 
45 79.00 ± 7.21 143.00 ± 1.50 173.67 ± 3.20 195.40 ± 5.52 
50 83.85 ± 7.42 158.00 ± 8.37 186.60 ± 3.30 212.70 ± 7.64 
55 91.45 ± 4.03 169.80 ± 1.11 203.30 ± 3.08 231.75 ± 0.48 
60 113.65 ± 2.86 180.57 ± 1,22 221.20 ± 2.74 244.70 ± 1.27 
90 122.05 ± 2.24 197.63 ± 1.41 236.07 ± 3.06 278.80 ± 3.11 
120 150.45 ± 5.58 215.13 ± 1.71 253.80 ± 2.35 336.30 ± 4.24 
180 170.40 ± 5.52 267.33 ± 2.60 291.27 ± 9.15 351.95 ± 2.47 
240 192.20 ± 1,51 348.17 ± 7.23 321.83 ± 1.65 748.50 ± 0.42 
300 209.30 ± 1.38 412.77 ± 1.11 352.27 ± 1.20 1037.60 ± 7.05 
360 235.10 ± 1.66 471.87 ± 7.66 372.93 ± 9.88 1290.15 ± 1.48 
420 264.6 ± 5.37 519.10 ± 7.33 393.67 ± 1.11 1293.05 ± 0.21 
480 300.65 ± 2.79 584.33 ± 4.28 418.83 ± 8.7 1293.45 ± 0.21 
 
 
TABLE 4: CURCUMIN TRANSETHOSOME DIFFUSION RATE KINETICS 
Formula Parameter 
Diffusion Rate Kinetics 
Zero 
Order 




(t, ln Qt / 
Qo) 
Higuchi 




( ln t , ln Qt / Qo) 
F1 R 0.9776 0.8837 0.9948 0.6698 
 k 0.5383 0.0042 13.3708 37.9701 
 n - - - 0.1111 
F2 R 0.9942 0.9295 0.9902 0.9802 
 k 1.0682 0.0043 25.9698 88.5617 
 n - - - 0.1066 
F3 R 0.9256 0.7887 0.9944 0.8858 
 k 0.8309 0.0036 12.9101 67.6806 
 n - - - 0.0977 
F4 R 0.9676 0.9443 0.9532 0.9872 
 k 2.7019 0.0057 13.3708 66.1947 




Fig. 1: Percentage Value of Entrapment Efficiency of Curcumin 
 
 




























































Fig 3: Drug release kinetic (Zero-order) 
 














































































Fig 5: Drug release kinetic (Higuchi Model) 
 











































































Legends of Tables and Figures 
TABLE 1: FORMULATION OF TRANSETHOSOME CURCUMIN  
Each batch contains 3 transethosome in each formulas, values are in % w/w 
TABLE 2: TEST RESULTS OF THE  PARTICLE SIZE, POLYDIPERSION 
INDEX AND ZETA POTENSIAL OF TRANSETHOSOME CURCUMIN 
a: Avg±SD, n=3; b: Avg±SD, n=3; c: Avg±SD, n=3 
TABLE 3 : CUMULATIVE RELEASE OF CURCUMIN 
a: Avg±SD, n=3; b: Avg±SD, n=3; c: Avg±SD, n=3; d: Avg±SD, n=3 
TABLE 4: CURCUMIN TRANSETHOSOME DIFFUSION RATE KINETICS 
Fig. 1: Percentage Value of Entrapment Efficiency of Curcumin 
Avg of entrapment efficiency, n=3 
Fig 2: Profile of diffused cumulative amount of curcumin 
F1 (-♦-); F2 (-■-); F3 (-▲-); F4 (-×-) 
Fig 3: Drug release kinetic (Zero-order) 
F1 (-■-); F2 (-▲-); F3 (-×-); F4 (-♦-)  
Fig 4: Drug release kinetic (First-order) 
F1 (-■-); F2 (-▲-); F3 (-×-); F4 (-♦-)  
Fig 5: Drug release kinetic (Higuchi Model) 
F1 (-■-); F2 (-▲-); F3 (-×-); F4 (-♦-)  
Fig 6: Drug release kinetic (Korsmeyer-Peppas Model) 
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Allicin, a natural organosulfur compound, is the main garlic ingredient, which has 
extensive pharmacological activities. Its unstable under acidic conditions due to 
alliinase's inactivation causes the need for preparations that delayed-release in the 
stomach to maximize allicin absorption. This study aimed to prepare and characterize the 
enteric-coated microsphere of phytosome loading allicin-rich extract to protect it from 
gastric acid. Optimized allicin-rich extract phytosome (ArE-Ps) has a size of 251.6 nm, 
polydispersity index 0.466, zeta potential 34.11, entrapment efficiency of 62.62%, and 
specific gravity of 1,005g/mL. Microsphere was made in three formulas with different 
molar ratios of ArE-Ps and Eudragit L30D-55 (1:1; 1:1.5 and 1:2) by spray dry. The 
surface topography of the three formulas shows an almost spherical shape with concave 
surfaces. The particle size of the microsphere ranges from 215 ± 6.27nm to 548.8 ± 
10.15nm. Entrapment efficiency increases with an increasing number of polymers with a 
maximum value of 65.44% at F3. The results dissolution test in vitro showed no drug 
release in acidic medium, and drug release occurred at a 7.4 pH medium. Drug release of 
three microsphere formulation followed the Korsmeyer-Peppas model with a k value of 
12.7088 ± 0.1769; 17,9322 ± 1,5621; and 12,958 ± 1,2677; respectively. Based on these 
results, the polymer's increase in three microsphere formulation can affect characteristics 
and retain drug release under acidic conditions. 
 
Keywords: enteric-coated, delayed-release, phytosome, allicin-rich extract, 
characterization  
 
Garlic (Allium sativum L.) is a bulbous plant that is easy to grow at temperatures 
and tropical conditions globally, including Indonesia. Generally, garlic used as a 
flavoring agent and seasonings (1). This plant has many organosulfur compounds such as 
allicin, volatile compounds (2). That reported having extensive pharmacological activities 
(3) such as antimicrobial (4), antihypertensive, nephroprotective, cardioprotective, 
antioxidant (5), anti-carcinogenic, antidiabetic, and cytochrome activity (2). Allicin is 
known to be unstable and results from the action of the alliinase enzyme in alliin. 
Formulations containing allicin are complicated because of their instability. Conventional 
formulations to form allicin in vivo also have a big challenge because alliinase destroyed 
by gastric acid (6). 
One of the new vesicular complexes is a phytosome made from the encapsulation 
of phospholipid and extracts into phytoconstituents to improve bioavailability and 
enhance therapeutic benefits in oral and topical use. Phytosome technology is considered 
a suitable method for obtaining a better pharmacodynamic and pharmacokinetic profile 
for active constituents in extracts because the structure of the vesicles protects the herbs 
from being damaged in an acidic environment. Increased penetration into the 
biomembrane can achieve with lipid-containing vesicle complexes (7). The research 
conducted by Almajdoub shows that the phosphatidylcholine that forms the phytosome 
experiences instability in gastric fluid pH simulation (8). Another study stated that the 
enzyme alliinase in garlic extract, which converts alliin compounds into allicin 
deactivates at the pH of gastric acid. That causes the reduction of allicin compounds to 
99% in the product (3). Based on this, the phytosomes system made into an enteric-coated 
preparation, Eudragit L30 D55. Enteric-coated preparations prevent the drug's release in 
the stomach and release at a more suitable place, the intestine (9,10). 
Polymeric Eudragit is a series of acrylic and methacrylate polymers available in 
various forms of ions. Eudragit L30D-55, with a molecular weight of 320,000 g/mol (11), 
is an anionic copolymer containing free carboxyl groups and esters in a ratio of 1: 1. The 
carboxyl group ionized in an aqueous medium at a pH of 5.5 and above makes the 
polymer resistant to the stomach's acidic environment but dissolves at intestinal pH (12). 
Spray dryer performed enteric coating—this method widely used to make microparticles, 
such as microspheres, with polymers containing hydrophilic, lipophilic, and 
macromolecular drugs (13). The main advantages are that the process is only one step, 
easy to control and improve, and possibly free from organic solvents (13). This study 
expected that the formed microparticles could be protected from the acidic environment 
and released in the intestinal environment. 
The concentration of enteric coating polymers influences microparticles' 
characteristics and their drug release in the gastrointestinal tract. A study conducted by 
Pyar and Peh in drug release tests in vitro showed that the concentration of L30D-55 
Eudragit above 7.5% was able to hold active substances in the stomach environment (14). 
Based on this, research carried out on increased Eudragit L30D-55 as an enteric-coated 
polymer on characterizing the microsphere allicin-rich extract phytosome (ArE-Ps) to 
protect it from gastric acid.  
MATERIALS AND METHODS: 
The materials used include an allicin-rich extract (Lansida), soy lecithin 
(Lansida), S-allyl 2-propane-1-sulfinothioate (Sigma Aldrich), Eudragit L30D-55 
(Evonik). All other reagents used analytical grade.  
Preparation of phytosome: 
A-4.5gram of ArE and soy lecithin weighed, respectively. Then soy lecithin 
diluted with dichloromethane, while ArE diluted with 96% ethanol. Both solutions mixed 
in a round-bottom flask. The solvent evaporated using a rotary evaporator (EYELA) at 
30°C with 125 rpm. Then, a thin layer formed stored in a refrigerator for up to 24 hours at 
7°C and hydrated with a phosphate buffer solution pH 5.5. Then, suspension sonicated 
for 60 minutes. 
Evaluation of phytosome: 
Phytosome evaluated to characterize the vesicle produced. Evaluations include 
entrapment efficiency, particle morphology, particle size, index polydispersity, potential 
zeta, and specific gravity. 
Preparation of phytosome-loaded microsphere: 
Phytosome-loaded microsphere formulations can see in Table 1. The polymer 
amount is proportional to the weight of solid phytosome in 1:1; 1:1.5; and 1:2 for F1, F2, 
and F3, respectively. Eudragit L30D-55 was mixing with triethyl citrate and aqua dest to 
make a polymer solution. The dispersion of polymer and phytosome suspension dried 
with 150°C as inlet temperature and 70°C as outlet temperatures to obtain microsphere by 
spray dryer (BUCHI 190). 
Entrapment efficiency determination: 
 The entrapment efficiency determined by breaking 200mg microcapsule by 
dissolved in phosphate buffer pH 7.4, then centrifuged at 10,000 rpm for 10min—1mL 
supernatant taken to measure allicin levels, which are not absorbed in the phytosome 
vesicles. Furthermore, the volume is sufficient with a mixed solvent phosphate pH 6.8 
and 95% ethanol (2:8), until 10mL. A-0.5 mL is taken and diluted into a 10 mL 
volumetric flask, and absorbance is measured using a UV-Vis spectrophotometer (1601-
SHIMADZU). Measurement of absorbed-allicin in the phytosome, centrifuge precipitate 
diluted 0.5mL dichloromethane, and vortexed. Then, it diluted in a 10mL volumetric 
flask, and the absorbance is measured. The percentage of absorbed-allicin determined 
using the formula, %EE=(M1-M2)/M1x100, where M1 is the total allicin in the 
microcapsule, and M2 is allicin concentration in supernatant. 
Morphology of microspheres: 
Morphology of microsphere evaluated using scanning electron microscopy (SEM 
JEOL JSM-6510LA). The microsphere is attached to the holder then inserted into a 
vacuum evaporator. At a specific vacuum level, the holder is incandescent so that gold 
vapor will coat the material attached to the holder. The holder is then inserted into the 
SEM device and then examined 
Particle size distribution: 
Particle size distribution and zeta potential were measured using particle size 
analyzer (Delsa Max Pro). Some 200mg of microcapsules dispersed in aqua pro injection 
in a ratio of 1:19. Then it is directly inserted into particle size analyzer, and the particle 
size distribution curve is determined. Zeta potential and polydispersity index 
measurements also performed. 
In vitro drug release studies: 
Procedure on this study refers to Anwar et al. (15). The allicin releases from 
microcapsule carried out in two types of mediums, hydrochloric acid pH 1.2 and 
phosphate buffer pH 7.4. Drug release testing carried out on a glass beaker placed on a 
magnetic stirrer at 37º±0.5ºC and 100rpm, the medium used was 100mL. Some 
microcapsules inserted into the cellophane membrane and dipped in the dissolution 
medium. The liquid sample is taken as much as 10mL at a particular minute. On the 
acidic medium, samplings carried out at minutes of 5, 10, 15, 30, 45, 60, 90, 120, 180, 
240, 300, 360, and 420. While on the pH 7.4 medium, samplings carried out at minutes of 
5, 10, 15, 30, 45, 60, 90, 120, and 180. Every 10mL sample liquid taken, then 10mL of 
the medium solution was added to the dissolution flask, in triplicate. Then allicin levels 
determined by UV-Vis spectrophotometer. 
Release kinetic models: (16,17) 
Mechanism of releasing allicin from three microspheres studied from the 
calculation with four different kinetic models was performed based on experimental data. 
Model 1 given by the Ritger-Peppas and Korsmeyer Peppas equations, f1=Mi/M∞=K.t
n, 
where f1 is the amount of drug released, M∞ and Mi is the amount of drug at the 
equilibrium state and over time t, respectively; K is the constant of incorporation of 
structural modifications and geometrical characteristics of the system, and n is the 
exponent of release in the function of time t. For the spherical delivery system, when 
n=0.43, the drug release mechanism is the Fickian diffusion. When n=0.85, the drug 
release mechanism is ultimately Case II transport. When 0.43>n>0.85, anomalous 
transport observed. 
Model 2 is the Higuchi model. Although this model is frequently used to describe 
the drug transport mechanism of thin-film hydrogels, this model can also be used to 
analyze spherical hydrogel systems' transport mechanism —the equation, f1=KH√t, where 
KH is the release constant of Higuchi. 
Model 3 is based on the zero-order drug delivery and expressed when n=1 in 
Korsmeyer Peppas equation, fi=K0.t, where fi=1−(Wi/W0) represents the fraction of active 
agent dissolved during the time t, and K0 is a constant of the apparent velocity of 
dissolution. 
Model 4 represent first-order drug delivery, and expressed by the following 
equation, logQ1=logQ0+(k1.t/2.303), where Q1 is the amount of active agent released on 
time t, Q0 is the initial amount of drug dissolved, and K1 is the first-order constant. 
Statistical analysis: 
One-way Analysis of Variance (ANOVA) analyzed dissolution rate data with a 
confidence level of 95% (α = 0.05) to determine any differences in all formulas. Then, 
further test by Tukey HSD to determine significant differences in each formula. 
RESULT AND DISCUSSION 
Before use, ArE preformulated by various evaluations parameter presented in 
Table 2. Organoleptic observation gives a physical form, color, smell, and taste of the 
extract. The water content and acid-insoluble ash of ArE was a meet requirement. While 
total ash content showed exceed form requirement. These results are the same as those 
obtained by Phan et al. (18), total-ash value of 3.5-3.7% by gravimetric method, wherein 
mineral content associated with raw garlic condition used and planting grounds. Allicin 
(S-Allyl-2-propene-1-sulfinothioate) is a volatile compound; allicin in extracts identified 
using gas chromatography with a mass spectrometer detector. The chromatogram (fig. 1) 
showed a similar peak between extract sample and standard allicin at a retention time of 
7.72 min. Allicin calibration curve equation is y=-0.0497 + 0.0520x with a correlation 
coefficient (R) of 0.9981 by spectrophotometric. Based on the curve, allicin concentration 
in extract was 11.29%; it becomes a reference in preparing phytosome. 
Optimal conditions for preparing phytosomes are using 4.5g ArE, 4.5g soy 
lecithin rotated with a temperature of 30˚C and speed of 125 rpm.  Soy lecithin is a 
phospholipids source with a higher proportion of around 76% phosphatidylcholine with a 
high content of polyunsaturated fatty acids, such as linoleic acid, about 70%, linolenic 
acid and oleic acid (19). Based on TEM result in fig. 2, phytosome vesicles have a round 
shape with varying sizes. This shape formed after the choline head of molecule binds 
with phytoconstituents, and the fat-soluble part of phosphatidylcholine then encloses the 
material bound to choline. It produces small cells such as micelles in the water 
environment. The vesicle size from TEM is not far from the PSA around 200nm. 
 Microsphere, made in three formulas with different molar ratios of ArE-Ps and 
Eudragit L30D-55 (1:1; 1:1.5 and 1:2) by spray dry, produce different sizes. Based on the 
result, the microsphere size was 548.8 nm, 215.0 nm, and 335.3 nm, respectively, for F1, 
F2, and F3. Particle size from spray drying can be influence by the size of the nozzle, 
viscosity of the polymer solution, dispersion of the active substance in the polymer 
solution, and surface tension (20). There are significant differences in the three formulas 
in the particle size values from the results of data analysis with differences in the 
concentration of Eudragit L30D-55 polymers. Microsphere of F1 have zeta potential 
below -30mV to allow agglomeration between particles to make the particle size larger.  
Nanoparticles with zeta potential below - 30 mV and above +30 mV have good 
suspension stability because the surface charge5 prevents aggregation between particles 
(15). Zeta potential values F1, F2, and F3 respectively; -28.88 ± 0.81; -32.15 ± 1.29; and 
-30.20 ± 0.61. The results show that only F2 and F3 can prevent aggregation between 
particles because they have a negative potential zeta value below -30 mV.  
The morphological structure presented in fig. 3, microsphere appears as an 
irregular shape with many deflections, no uniform sizes, and no porous surface. Nijdam 
and Langrish estimate that giving a high temperature causes water to evaporate faster and 
gives a non-uniform structure (21). During the high-temperature drying process, the 
evaporation of water solvent molecules in the droplet occurs so rapidly that it causes 
"emptiness" in the droplet whose surface has formed a film layer and results in the form 
of rounded particles that deflate (22).  
The in vitro dissolution profile of microsphere from all formulations in acidic 
medium (pH 1.2) and phosphate buffer medium (pH 7.4) shown in fig. 4. In acidic 
medium for 480 minutes, all formulation shows no allicin release, marked with the 
absence of absorbance in the sample taken. It proves that Eudragit from all three 
formulations can retain the release of allicin in acidic medium. The microsphere of F1 
and F2 in alkaline pH 7.4, began to release allicin at 45 min by 55.23±0.00% and 
61.26±0,66%. At the same time, F3 microcapsules release allicin at 60 min by 
59.50±1.85%. The F3 microsphere retains allicin release longer because it contains more 
polymers than F1 and F2. Release of allicin caused by salt formation between the 
polymer Eudragit with alkali at pH 7.4 so the polymer layer can dissolve. The 
microsphere of F1 and F2 dissolve entirely in the 120 min, while F3 in the 180 min. The 
different rates of dissolving active substances released from the microsphere influenced 
by the thickness of the coating wall and surface pores. Less amount of constituent 
polymers, thinner coating walls allow the release of active substances faster in phosphate 
buffer pH 7,4. 
Furthermore, dissolution percent of microsphere from all formulation analyzed 
by fitting them to four model drug releases kinetics equations such as kinetics of zero-
order, first-order, Higuchi and Korsmeyer-Peppas. From each equation, we get the drug 
release constant (k), correlation coefficient (r), and exponent dissolution of Peppas (n). 
Based on Table 6, allicin release from the microsphere follows the Korsmeyer-
Peppas kinetics. The Korsmeyer-Peppas equation explains the mechanism of drug release 
from preparations based on the Fickian model mechanism is the same as Higuchi. In the 
Korsmeyer-Peppas equation, the release mechanism depends on the value 'n' when n = 
0.43 the Fickian diffusion governs the drug release mechanism when 0.43 < n < 0.85 it is 
anomalous (non-Fickian) transport, and when n = 0.85 it is case II transport (16). The n 
values of all formulation <0.45 indicate the release mechanism follows the Fickian 
model. According to Fickian, the dissolution rate of solid form determined by the 
dissolution rate of a thin layer of a solution formed around the solid. The drug dissolved 
in a saturated solution diffuses into the solvent from high concentration to an area of low 
drug concentration. 
Data on the dissolution rate analyzed statistically to see the differences between 
the three formulas. The normality test resulted in sig values of 0.247; 0.429; dan 0.075 
(sig >0.05); then, the homogeneity test resulted in sig values of 0.056 (sig >0.05); it 
concluded the data typically distributed and homogeneous. Furthermore, a one-way 
ANOVA test resulted in sig values of 0.002 (sig <0.05); it concluded a significant 
difference in the dissolution rate of microsphere between all formulations. 
Based on these results, the polymer's increase in three microsphere formulation 
can affect characteristics and retain drug release under acidic conditions. The three 
formulations follow Korsmeyer-Peppas kinetics release with k values 12.71±0.18; 
17.93±1.56; and 12.96±1.27, for F1, F2, and F3, respectively. 
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TABLE 1: FORMULA OF ArE-Ps MICROSPHERE 
Materials (Units) 
Concentration 
F1 F2 F3 
Phytosome (%) 
Eudragit L30 D55 (%) 
Triethyl citrate (%) 


















TABLE 2: CHARACTERISTICS OF ArE 






Water content (%) 

















No more 12 
No more 2.7 
No more 0.7 
 
 
Fig. 1: Chromatogram of S-Allyl-2-propene-1-sulfinothioate from ArE (a) and 
standard allicin (b) 
 
TABLE 3: CHARACTERIZATION OF ArE-Ps OPTIMUM FORMULATION 
Parameters (Units) Result 
Entrapment efficiency (%) 
Dmean (nm) 
Polydispersity index (PDI) 
Zeta potential 








Fig. 2: Morphology of ArE-Ps using TEM  


































Fig. 3: Morphological structure of 5000x magnification microcapsules (a) ratio 1:1 
(b) ratio 1:1.5 (c) ratio 1:2  
 
Fig. 4: Percent dissolution of the microsphere in a buffer medium pH of 7.4 
















































y = 0,403x + 2,5339
R² = 0,8805
y = 0,3462x + 2,8865
R² = 0,8461






















y = 5,9776x + 20,431
R² = 0,8197y = 5,5392x + 32,321
R² = 0,7984

























Fig. 5: Drug release kinetics plots for all formulations (a) Korsmeyer-Peppas (b) 
Higuchi (c) Zero-order (d) First-order 
Table and figure titles and legends: 
TABLE 1: ArE-Ps MICROSPHERE FORMULATION 
ArE-Ps is a phytosome of allicin-rich extracts. 
TABLE 2: ArE CHARACTERIZATION RESULT 
ArE is an allicin-rich extract, this characterization as a pre-formulation test. 
TABLE 3: OPTIMUM FORMULATION OF ArE-Ps CHARACTERIZATION RESULT 
ArE-Ps is phytosome of allicin-rich extract, and optimum formulation comes from 
optimation by CCD-RSM. 
TABLE 4: MICROSPHERE EVALUATION RESULTS 
ArE-Ps: Eud is a ratio of Eudragit L30D-55 polymer amount is proportional to the weight 
of solid allicin-rich extract of phytosome. 
TABLE 6: KINETICS OF ALLICIN RELEASE IN MICROSPHERE 
Values calculated from the average value of 3 measurements. 
Fig. 1: Chromatogram of S-Allyl-2-propene-1-sulfinothioate from ArE (a) and 
standard allicin (b) 
Fig. 2: Morphology of ArE-Ps using TEM 
Phytosome on the small image enlarged to a large image. 
Fig. 3: Morphological structure of 5000x magnification microcapsules (a) ratio 1:1 
(b) ratio 1:1.5 (c) ratio 1:2 
Fig. 4: Percent dissolution of the microsphere in a buffer medium pH of 7.4 
Fig. 5: Drug release kinetics plots for all formulations (a) Korsmeyer-Peppas (b) 
Higuchi (c) Zero-order (d) First-order 
y = 0,2815x + 50,32
R² = 0,7428
y = 0,2592x + 60,184
R² = 0,7142






















c y = 0,0038x + 3,966
R² = 0,7303y = 0,0032x + 4,1219
R² = 0,6801












3 0 8 0 1 3 0 1 8 0 2 3 0
In
 %
 d
ru
g 
re
le
as
e
time (min)
d
